Headlands Research Acquires Clinvest Research


Headlands Researchhas announced the acquisition of Clinvest Research, an established site based in Springfield, Missouri. Founded in 1996, Clinvest Research has conducted over 600 trials for chronic diseases and conditions such as headache and migraine, arthritis and chronic pain, and diabetes, as well as weight loss.

By combining Clinvest Research’s expertise with the 11 other sites in the Headlands Research site network studying chronic conditions, Headlands Research is able to access a greater participant population for clinical trials conducted in the US and Canada.

Headlands Research also recently announced the launch of Headlands Research Detroit as well as the acquisition of Headlands Eastern Massachusetts and has plans to continue expanding its network throughout 2023.


Headlands Research Acquires Clinvest Research — the Clinical Research Site Network’s Third Addition of 2023. (2023, May 4). Business Wire.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.